Veloxis Pharmaceuticals to Pay More Than $46 Million Over Kickback Schemes
Veloxis has agreed to pay more than $46 million to resolve criminal and civil liability tied to kickback schemes involving healthcare providers and specialty pharmacies, the Justice Department said Monday. The North Carolina drugmaker entered into a deferred prosecution agreement connected to a criminal conspiracy charge and agreed to settlements covering alleged false claims submitted to federal healthcare programs and failures to properly disclose payments to physicians.
